Anti‐cachectic Effect of FK317, a Novel Anti‐cancer Agent, in Colon26 and LX‐1 Models in Mice

por Naoe, Yoshinori, Kawamura, Ikuo, Inami, Masamichi, Matsumoto, Sanae, Nishigaki, Fusako, Tsujimoto, Susumu, Manda, Toshitaka, Shimomura, Kyoichi
Publicado 1998

Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity

por Naoe, Yoshinori, Inami, Masamichi, Kawamura, Ikuo, Nishigaki, Fusako, Tsujimoto, Susumu, Matsumoto, Sanae, Manda, Toshitaka, Shimomura, Kyoichi
Publicado 1998

Different Effects of FK317 on Multidrug‐resistant Tumor in vivo and in vitro

por Naoe, Yoshinori, Inami, Masamichi, Takagaki, Shoji, Matsumoto, Sanae, Kawamura, Ikuo, Nishigaki, Fusako, Tsujimoto, Susumu, Manda, Toshitaka, Shimomura, Kyoichi
Publicado 1998

FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice

por Naoe, Yoshinori, Inami, Masamichi, Matsumoto, Sanae, Takagaki, Shoji, Fujiwara, Tomoichi, Yamazaki, Sachiko, Kawamura, Ikuo, Nishigaki, Fusako, Tsujimoto, Susumu, Manda, Toshitaka, Shimomura, Kyoichi
Publicado 1998